45.49
price down icon2.84%   -1.34
 
loading
전일 마감가:
$46.83
열려 있는:
$46.82
하루 거래량:
156.19K
Relative Volume:
0.16
시가총액:
$4.69B
수익:
-
순이익/손실:
$-746.61M
주가수익비율:
-6.0897
EPS:
-7.47
순현금흐름:
$-485.24M
1주 성능:
-6.49%
1개월 성능:
-11.38%
6개월 성능:
+17.51%
1년 성능:
+54.08%
1일 변동 폭
Value
$45.00
$47.66
1주일 범위
Value
$43.18
$49.56
52주 변동 폭
Value
$26.80
$62.21

바이오헤이븐 Stock (BHVN) Company Profile

Name
명칭
Biohaven Ltd
Name
전화
203-404-0410
Name
주소
215 CHURCH STREET, NEW HAVEN, CT
Name
직원
239
Name
트위터
@biohavenpharma
Name
다음 수익 날짜
2022-11-07T13:30:00.000Z
Name
최신 SEC 제출 서류
Name
BHVN's Discussions on Twitter

BHVN을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
BHVN 45.54 4.69B 0 -746.61M -485.24M -7.47
VRTX 448.24 115.74B 10.63B -479.80M -1.35B 13.33
REGN 747.08 81.65B 13.85B 4.65B 3.32B 35.06
ARGX 591.26 34.86B 1.86B -40.29M -1.28B -4.16
ALNY 249.69 32.09B 2.09B -332.26M 16.06M -4.14
BNTX 103.79 24.49B 3.30B -501.07M 1.03B 11.54

바이오헤이븐 Stock (BHVN) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-09-16 개시 Jefferies Buy
2024-09-04 개시 Bernstein Outperform
2024-07-24 개시 Morgan Stanley Overweight
2024-02-16 개시 RBC Capital Mkts Outperform
2024-02-06 개시 UBS Buy
2023-12-22 개시 H.C. Wainwright Buy
2023-12-08 개시 Robert W. Baird Outperform
2023-01-24 개시 SVB Securities Outperform
2023-01-04 개시 JP Morgan Overweight
2022-12-02 개시 BTIG Research Buy
2022-10-26 업그레이드 Cantor Fitzgerald Neutral → Overweight
2022-10-12 개시 Piper Sandler Overweight
2022-08-19 다운그레이드 Piper Sandler Overweight → Neutral
2022-08-08 다운그레이드 Wedbush Outperform → Neutral
2022-05-11 다운그레이드 SVB Leerink Outperform → Mkt Perform
2021-10-19 재개 Morgan Stanley Equal-Weight
2021-08-10 다운그레이드 UBS Buy → Neutral
2021-08-03 재확인 Canaccord Genuity Buy
2021-03-11 개시 UBS Buy
2020-12-15 개시 H.C. Wainwright Buy
2020-04-17 개시 Cowen Outperform
2020-02-10 다운그레이드 Oppenheimer Outperform → Perform
2020-02-06 개시 Mizuho Buy
2019-11-22 개시 Wedbush Outperform
2019-06-25 재확인 Canaccord Genuity Buy
2019-05-06 개시 Goldman Buy
2019-04-09 다운그레이드 Morgan Stanley Overweight → Equal-Weight
2019-03-04 재확인 Needham Buy
2018-07-03 재확인 Needham Buy
2018-07-02 재확인 Needham Buy
2018-04-05 다운그레이드 Barclays Overweight → Equal Weight
2018-02-22 재확인 Canaccord Genuity Buy
2017-12-15 개시 Canaccord Genuity Buy
2017-10-03 재확인 Needham Buy
모두보기

바이오헤이븐 주식(BHVN)의 최신 뉴스

pulisher
Nov 20, 2024

Multiple System Atrophy Market Growth to Accelerate in Forecast Period (2024-2034), DelveInsight Analyzes | Ionis Pharma, Biohaven Pharma, Lundbeck A/S, Alterity Therapeutics, Theravance Biopharma - The Globe and Mail

Nov 20, 2024
pulisher
Nov 20, 2024

Psoriasis Market is expected to rise at a significant CAGR, DelveInsight | Hangzhou Highlightll Pharmaceutical Co., Ltd, Biohaven Pharmaceuticals, Inc., SFA Therapeutics, Bristol-Myers Squibb - Barchart

Nov 20, 2024
pulisher
Nov 19, 2024

Biohaven Ltd. (NYSE:BHVN) Shares Sold by First Turn Management LLC - MarketBeat

Nov 19, 2024
pulisher
Nov 19, 2024

Victory Capital Management Inc. Buys 145,960 Shares of Biohaven Ltd. (NYSE:BHVN) - MarketBeat

Nov 19, 2024
pulisher
Nov 16, 2024

Biohaven (NYSE:BHVN) Stock Price Down 8%Should You Sell? - MarketBeat

Nov 16, 2024
pulisher
Nov 14, 2024

Janus Henderson Group PLC's Strategic Acquisition of Biohaven Lt - GuruFocus.com

Nov 14, 2024
pulisher
Nov 14, 2024

Biohaven's (BHVN) Buy Rating Reaffirmed at HC Wainwright - MarketBeat

Nov 14, 2024
pulisher
Nov 13, 2024

Biohaven Reports Third Quarter 2024 Financial Results and Recent Business Developments - The Malaysian Reserve

Nov 13, 2024
pulisher
Nov 13, 2024

Biohaven shares rise as TD Cowen lifts price target to $75 - Investing.com Australia

Nov 13, 2024
pulisher
Nov 13, 2024

Royal Bank of Canada Issues Pessimistic Forecast for Biohaven (NYSE:BHVN) Stock Price - MarketBeat

Nov 13, 2024
pulisher
Nov 11, 2024

12,400 Shares in Biohaven Ltd. (NYSE:BHVN) Acquired by SpiderRock Advisors LLC - MarketBeat

Nov 11, 2024
pulisher
Nov 10, 2024

Trend Tracker for (BHVN) - Stock Traders Daily

Nov 10, 2024
pulisher
Nov 07, 2024

Brokerages Set Biohaven Ltd. (NYSE:BHVN) Price Target at $61.92 - MarketBeat

Nov 07, 2024
pulisher
Nov 05, 2024

Biohaven Stock Soars on Drug Trial Results: Time to Jump In? - MSN

Nov 05, 2024
pulisher
Nov 05, 2024

Vanguard Group Inc's Strategic Acquisition in Biohaven Ltd - GuruFocus.com

Nov 05, 2024
pulisher
Oct 31, 2024

(BHVN) Technical Data - Stock Traders Daily

Oct 31, 2024
pulisher
Oct 23, 2024

Biohaven's (BHVN) "Overweight" Rating Reiterated at Cantor Fitzgerald - MarketBeat

Oct 23, 2024
pulisher
Oct 20, 2024

Cadent Capital Advisors LLC Invests $1.77 Million in Biohaven Ltd. (NYSE:BHVN) - MarketBeat

Oct 20, 2024
pulisher
Oct 20, 2024

(BHVN) Trading Advice - Stock Traders Daily

Oct 20, 2024
pulisher
Oct 16, 2024

Scholar Rock stock could benefit from Biohaven's Ph3 results, Truist raises potential rally outlook - Investing.com India

Oct 16, 2024
pulisher
Oct 15, 2024

BofA sustains Buy rating on Biohaven shares, sees SMA trial upside By Investing.com - Investing.com South Africa

Oct 15, 2024
pulisher
Oct 15, 2024

BofA sustains Buy rating on Biohaven shares, sees SMA trial upside - Investing.com UK

Oct 15, 2024
pulisher
Oct 13, 2024

Analysts Set Biohaven Ltd. (NYSE:BHVN) Target Price at $61.92 - MarketBeat

Oct 13, 2024
pulisher
Oct 11, 2024

Biohaven: A Complicated Tale (NYSE:BHVN) - Seeking Alpha

Oct 11, 2024
pulisher
Oct 10, 2024

Biohaven Ltd. (NYSE:BHVN) Shares Acquired by AQR Capital Management LLC - MarketBeat

Oct 10, 2024
pulisher
Oct 09, 2024

(BHVN) Investment Analysis - Stock Traders Daily

Oct 09, 2024
pulisher
Oct 09, 2024

17,064 Shares in Biohaven Ltd. (NYSE:BHVN) Acquired by Squarepoint Ops LLC - MarketBeat

Oct 09, 2024
pulisher
Oct 07, 2024

Biohaven retains Outperform stock rating on clinical results By Investing.com - Investing.com South Africa

Oct 07, 2024
pulisher
Oct 07, 2024

Biohaven holds steady with $60 target on SMA trial optimism - Investing.com India

Oct 07, 2024
pulisher
Oct 07, 2024

Biohaven holds steady with $60 target on SMA trial optimism By Investing.com - Investing.com Australia

Oct 07, 2024
pulisher
Oct 07, 2024

Biohaven maintains Buy rating with $59 target amid SMA trial optimism By Investing.com - Investing.com South Africa

Oct 07, 2024
pulisher
Oct 07, 2024

Biohaven (NYSE:BHVN) Stock Price Up 4.9%Here's What Happened - MarketBeat

Oct 07, 2024
pulisher
Oct 06, 2024

Vladimir Coric Buys Handful Of Shares In Biohaven - Simply Wall St

Oct 06, 2024
pulisher
Oct 04, 2024

Cantor Fitzgerald Reiterates "Overweight" Rating for Biohaven (NYSE:BHVN) - MarketBeat

Oct 04, 2024
pulisher
Oct 04, 2024

Biohaven Stock Spikes After Drug Candidate To Treat Rare Neurodegenerative Disease Shows Promise - MSN

Oct 04, 2024
pulisher
Oct 04, 2024

Analysts’ Recent Ratings Changes for Biohaven (BHVN) - Defense World

Oct 04, 2024
pulisher
Oct 03, 2024

Biohaven (NYSE:BHVN) Price Target Raised to $68.00 at JPMorgan Chase & Co. - MarketBeat

Oct 03, 2024
pulisher
Oct 03, 2024

Biohaven (NYSE:BHVN) Shares Gap Up After Insider Buying Activity - MarketBeat

Oct 03, 2024
pulisher
Oct 03, 2024

John W. Childs Purchases 21,052 Shares of Biohaven Ltd. (NYSE:BHVN) Stock - Defense World

Oct 03, 2024
pulisher
Oct 03, 2024

Bullish Biohaven Insiders Loaded Up On US$41.7m Of Stock - Yahoo Finance

Oct 03, 2024
pulisher
Oct 03, 2024

Biohaven director Childs buys shares worth nearly $1 million By Investing.com - Investing.com South Africa

Oct 03, 2024
pulisher
Oct 03, 2024

Biohaven CEO Vlad Coric acquires $999,970 in company stock By Investing.com - Investing.com Australia

Oct 03, 2024
pulisher
Oct 03, 2024

Biohaven director Childs buys shares worth nearly $1 million - Investing.com

Oct 03, 2024
pulisher
Oct 03, 2024

Biohaven CEO Vlad Coric acquires $999,970 in company stock - Investing.com India

Oct 03, 2024
pulisher
Oct 03, 2024

Marshall Wace LLP Sells 677,724 Shares of Biohaven Ltd. (NYSE:BHVN) - MarketBeat

Oct 03, 2024
pulisher
Oct 02, 2024

Biohaven Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares - Lelezard.com

Oct 02, 2024
pulisher
Oct 02, 2024

Biohaven Ltd. (NYSE:BHVN) Shares Sold by Point72 Asset Management L.P. - MarketBeat

Oct 02, 2024
pulisher
Oct 01, 2024

Biohaven sets public offering price at $47.50 per share By Investing.com - Investing.com Australia

Oct 01, 2024
pulisher
Oct 01, 2024

Biohaven shares could see growth as MDD and bipolar studies advance, per TD Cowen - Investing.com India

Oct 01, 2024
pulisher
Oct 01, 2024

Biohaven (NYSE:BHVN) Sees Strong Trading Volume - MarketBeat

Oct 01, 2024
pulisher
Oct 01, 2024

Biohaven sets public offering price at $47.50 per share - Investing.com

Oct 01, 2024

바이오헤이븐 (BHVN) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$70.68
price down icon 0.42%
$18.62
price up icon 0.16%
$36.06
price down icon 1.68%
$364.60
price up icon 0.01%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
자본화:     |  볼륨(24시간):